Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
91 studies found for:    "inclusion body myopathy with early-onset Paget disease and frontotemporal dementia" OR "Frontotemporal Dementia" OR "Paget's Disease of Bone"
Show Display Options
RSS Create an RSS feed from your search for:
"inclusion body myopathy with early-onset Paget disease and frontotemporal dementia" OR "Frontotemporal Dementia" OR "Paget's Disease of Bone"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Characterization of Inclusion Body Myopathy Associated With Paget's Disease of Bone and Frontotemporal Dementia (IBMPFD)
Conditions: Inclusion Body Myopathy With Early-onset Paget Disease and Frontotemporal Dementia;   Paget Disease of Bone;   Frontotemporal Dementia;   Myopathy
Intervention:
2 Completed
Has Results
Memantine (10mg BID) for the Frontal and Temporal Subtypes of Frontotemporal Dementia
Conditions: Frontal Lobe Dementia;   Frontotemporal Lobe Dementia;   Semantic Dementia
Interventions: Drug: memantine;   Drug: Placebo pill
3 Completed Oxytocin and Social Cognition in Frontotemporal Dementia
Conditions: Frontotemporal Dementia;   Pick's Disease
Intervention: Drug: intranasal oxytocin
4 Completed Safety Study of Intranasal Oxytocin in Frontotemporal Dementia
Condition: Frontotemporal Dementia
Interventions: Drug: oxytocin;   Drug: Saline Nasal Mist
5 Completed Open Label Pilot Study of the Effects of Memantine on FDG-PET in Frontotemporal Dementia
Condition: Frontotemporal Dementia
Intervention: Drug: memantine hydrochloride
6 Terminated Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
Conditions: Frontotemporal Dementia;   Amyotrophic Lateral Sclerosis
Intervention:
7 Recruiting Impact of Emotional Mimicry and Oxytocin on Frontotemporal Dementia
Condition: Frontotemporal Dementia
Interventions: Drug: Intranasal oxytocin;   Drug: Saline Nasal Mist
8 Completed Serotonergic Function and Behavioural and Psychological Symptoms of Frontotemporal Dementia
Condition: Frontotemporal Dementia
Intervention: Drug: Citalopram
9 Unknown  Study of Social Behavior and Emotion in Frontotemporal Dementia, Alzheimer's Disease and Controls
Conditions: Frontotemporal Dementia;   Frontotemporal Degeneration;   Alzheimer's Disease;   Social Behavior
Intervention:
10 Completed A Pilot Study to Explore the Safety and Tolerability of Galantamine HBr in the Treatment of Pick Complex/Frontotemporal Dementia
Conditions: Frontotemporal Dementia;   Pick Complex
Intervention: Drug: galantamine hydrobromide
11 Recruiting Safety and Efficacy Study Evaluating TRx0237 in Subjects With Behavioral Variant Frontotemporal Dementia (bvFTD)
Condition: Behavioral Variant Frontotemporal Dementia (bvFTD)
Interventions: Drug: TRx0237;   Drug: Placebo
12 Enrolling by invitation Open-Label Study of TRx0237 in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)
Conditions: Alzheimer's Disease;   Behavioral Variant Frontotemporal Dementia
Intervention: Drug: TRx0237
13 Completed Direct Current Brain Polarization in Frontotemporal Dementia
Condition: Pick Disease of the Brain
Intervention: Procedure: Direct Current Polarization
14 Completed Genetic Study of Families Affected by Paget's Disease of Bone
Condition: Paget's Disease of Bone
Intervention:
15 Unknown  Far Infrared Irradiation for the Management, Control and Treatment of Frontotemporal Dementia
Condition: Pick Disease of the Brain
Intervention: Radiation: Radiation: Far Infrared Radiation (5μm to 20μm wavelength)
16 Completed 18F-Fluoride Positron Emission Tomography (PET) in Paget's Disease of Bone
Condition: Paget's Disease of Bone
Intervention: Drug: Bisphosphonate treatment
17 Completed Efficacy and Safety of Single Dose of 5 mg Zoledronic Acid in Chinese Patients With Paget's Disease of Bone (PDB)
Condition: Paget's Disease of Bone
Intervention: Drug: Zoledronic acid
18 Completed
Has Results
Safety and Efficacy Trial With Zoledronic Acid for the Treatment of Paget's Disease of Bone, Including an Extended Observation Period
Condition: Paget's Disease of Bone
Interventions: Drug: zoledronic acid;   Drug: placebo to zoledronic acid;   Drug: Risedronate;   Drug: Placebo to risedronate;   Drug: Calcium and vitamin D supplements
19 Completed
Has Results
Imaging Characteristics of Florbetapir 18F in Patients With Frontotemporal Dementia, Alzheimer's Disease and Normal Controls.
Conditions: Alzheimer's Disease;   Frontotemporal Dementia
Interventions: Drug: florbetapir 18F;   Drug: 18F-FDG
20 Recruiting Language in Primary Progressive Aphasia
Condition: Primary Progressive Aphasia
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years